Form 8-K · Current report
Globe Life 8-K, filed Jul 22, 2026
- Filed
- CIK
- 0000320335
- Accession no.
- 0000320335-26-000203
Summary
Globe Life Inc. reported second-quarter 2026 net income of $3.65 per diluted common share, up from $3.05 a year earlier, with net operating income of $3.61 per diluted share versus $3.27, and raised its full-year 2026 earnings guidance to a range of $15.55 to $15.95, a $0.10 increase at the midpoint.
Key points
- Net income per share rose 20% and net operating income per share rose 10% from the year-ago quarter.
- Book value per share was $78.18, up 18% year over year, and net income as an ROE was 18.4% for the six months ended June 30, 2026.
- Total premium revenue grew 7% over the year-ago quarter, to $1.30 billion.
- Globe Life repurchased 1.1 million shares of its common stock during the quarter at a total cost of $175 million.
Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.
Items reported
- 2.02Results of Operations and Financial Condition
- 9.01Financial Statements and Exhibits
From the filing
Item 2.02 Results of Operations and Financial Condition. On July 22, 2026, Globe Life Inc. issued a press release announcing its second quarter 2026 financial results. A copy of the press release is incorporated herein by reference and is provided as Exhibit 99.1. In accordance with General Instruction B.2 of Form 8-K, the information included or incorporated in this report (including Exhibit 99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”), nor shall such information be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as shall be set forth by specific reference…
An excerpt of the text as filed with the SEC, cut for length.
Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.